{{Rsnum
|rsid=960902
|Chromosome=2
|position=37504522
|Orientation=plus
|GMAF=0.4885
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 25.7 | 54.0 | 20.4
| HCB | 16.8 | 52.6 | 30.7
| JPT | 13.3 | 45.1 | 41.6
| YRI | 30.6 | 48.3 | 21.1
| ASW | 21.1 | 57.9 | 21.1
| CHB | 16.8 | 52.6 | 30.7
| CHD | 23.9 | 40.4 | 35.8
| GIH | 17.8 | 47.5 | 34.7
| LWK | 24.5 | 52.7 | 22.7
| MEX | 22.4 | 63.8 | 13.8
| MKK | 23.1 | 50.6 | 26.3
| TSI | 29.4 | 42.2 | 28.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22569225
|Trait=None
|Title=Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNF&#x003b1; inhibitors in patients with rheumatoid arthritis.
|RiskAllele=
|Pval=0.000008
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}